News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current NBIO market cap is 16.96M. The company's latest EPS is USD -0.0165 and P/E is -6.06.
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 750k | 1M | 0 |
| Operating Income | -1.37M | -3.45M | -1.4M | -457k | -2.14M |
| Net Income | -1.37M | -4M | -959k | -470k | -2.8M |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 131k | 3k | 751k | 105k | 255k |
| Total Liabilities | 614k | 2.88M | 1.22M | 776k | 1.55M |
| Total Equity | -483k | -2.88M | -473k | -671k | -1.3M |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -712k | -554k | -987k | 414k | -1.79M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 726k | 426k | 985k | -321k | 1.87M |
| Market Cap | 16.96M |
| Price to Earnings Ratio | -6.06 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 100 |
| Price to Book Ratio | -13.1 |
| Dividend Yield | - |
| Shares Outstanding | 169.73M |
| Average Volume (1 week) | 69.64k |
| Average Volume (1 Month) | 99.27k |
| 52 Week Change | 75.26% |
| 52 Week High | 0.28 |
| 52 Week Low | 0.0323 |
| Spread (Intraday) | 0.02 (19.92%) |
| Company Name | Nascent Biotech Inc (QB) |
| Address |
623 17th street vero beach, florida 32960 |
| Website | https://www.nascentbiotech.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
